CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $16,639,000 | -8.4% | 3,269,112 | +13.9% | 0.02% | -5.9% |
Q2 2021 | $18,160,000 | -15.2% | 2,868,986 | +3.6% | 0.02% | -22.7% |
Q1 2021 | $21,403,000 | +41.0% | 2,768,882 | +19.5% | 0.02% | +29.4% |
Q4 2020 | $15,179,000 | -6.0% | 2,317,397 | -4.5% | 0.02% | -19.0% |
Q3 2020 | $16,145,000 | -14.9% | 2,427,806 | +6.6% | 0.02% | -19.2% |
Q2 2020 | $18,967,000 | -55.4% | 2,276,960 | -58.9% | 0.03% | -27.8% |
Q1 2020 | $42,530,000 | +81.9% | 5,544,852 | +97.1% | 0.04% | +28.6% |
Q4 2019 | $23,380,000 | +20.8% | 2,813,451 | +7.3% | 0.03% | +12.0% |
Q3 2019 | $19,351,000 | -13.2% | 2,622,122 | +32.0% | 0.02% | -44.4% |
Q2 2019 | $22,283,000 | +25.2% | 1,985,990 | +20.0% | 0.04% | +12.5% |
Q1 2019 | $17,797,000 | +28.1% | 1,655,530 | +79.9% | 0.04% | +14.3% |
Q4 2018 | $13,895,000 | -15.6% | 920,210 | +3.3% | 0.04% | +2.9% |
Q3 2018 | $16,472,000 | +514.2% | 890,400 | +658.9% | 0.03% | +466.7% |
Q2 2018 | $2,682,000 | -24.0% | 117,320 | -5.4% | 0.01% | -25.0% |
Q1 2018 | $3,529,000 | – | 124,030 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |